ici 164384 has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Luise, M; Hu, XF; Huggins, R; Martin, TJ; Nadalin, G; Wakeling, A; Zalcberg, JR | 1 |
1 other study(ies) available for ici 164384 and Leukemia, Lymphocytic, T Cell
Article | Year |
---|---|
Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384.
Topics: Carcinoma, Small Cell; Cell Division; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Estradiol; Estrogen Antagonists; Humans; Leukemia, T-Cell; Lung Neoplasms; Polyunsaturated Alkamides; Tumor Cells, Cultured | 1991 |